PFE a close above $25.24 today means we have broken the out of the daily bearish trend.
PFIZER INC stock forum
PFE a close above $25.24 today means we have broken the out of the daily bearish trend.
PFE let’s break this upward trendline!!! 🚀💉
PFE finally moving higher. approaching a major bearish trend line.
PFE took my loss (-40% leveraged) on this one. Looks like it’s going down further
PFE Pfizer reported an 8% year-over-year drop in Q1 revenue, down to $13.7 billion—$370 million below expectations. However, adjusted earnings per share rose to $0.92, beating estimates by $0.24, thanks to strong cost management. COVID-related products continued to weigh on performance: Paxlovid sales plunged 76% year-over-year and missed forecasts, while Comirnaty jumped 62% and slightly exceeded projections. The company reaffirmed its 2025 revenue outlook of $61–$64 billion and adjusted EPS of $2.80–$3.00, though it cautioned that potential tariff effects haven't been factored in. Pfizer now targets $7.7 billion in cost reductions by 2027 through greater use of automation, AI, and streamlined processes.After scrapping its obesity pill program over safety issues, Pfizer is looking at acquisitions to revive its cardiometabolic pipeline. The company faces long-term challenges including patent cliffs, regulatory threats from possible drug pricing changes, and waning investor confidence. Although it's cutting costs and investing in its R&D pipeline to steady the ship, Wall Street doubts Pfizer can replace the massive earnings it made during the COVID boom with new blockbuster drugs.
PFE : not sure why pfe does not perform... i am owner of pfe. i enjoy the dividend but don't get why there is a buyers strike. Fool makes sense... pfe has to fill the pipeline. bought alt & vktx as well today.
PFE : possible to buy alt fool.com/investing/2025/04/30/will-pfizer-will-acquire-altimmune-or-viking-thera/
PFE After holding this security for over two years, we are downgrading this stock to sell from hold. After a series of poor decisions by management, they have proceeded to issue more new shares while slashing high impact projects like their weight loss drug, oncology pipeline, and research & development expense. We can no longer recommend this company with any level of certainty due to the very irresponsible use of capital, promises to shareholders that are getting broken quarter after quarter, and low after low. We don't see a reliable floor for this security anywhere at the moment. Very disappointed in the company and leadership. if they can even sustain their dividend remains to be seen.PFE this is going lower :(
doesn't seem like it'll hold 25